MHRA secures £3.6 million multi‑year funding to expand its AI Airlock regulatory sandbox for Artificial Intelligence as a Medical Device (AIaMD). The Department of Health and Social Care has allocated £1.2 million per year for 2026‑2029, enabling the programme to move beyond yearly budgets and support longer‑term testing models. AI Airlock, led by the MHRA with DHSC, NHS AI Team and Team AB, is a key part of the UK’s AI regulatory reform and aligns with the AI Opportunities Action Plan, the Regulatory Action Plan and the 10‑Year Health Plan. Executive Director James Pound said the boost “marks a pivotal moment for AI Airlock and for the safe and responsible advancement of AI in healthcare.” The programme’s second phase, covering diagnostics, large‑language models and voice tools, will report findings in summer 2026 and shape phase three. The initiative helps regulators and industry collaborate on challenges, strengthening patient safety and market for medical technology.
© Crown copyright, 2024, GOV.UK.
Summary adapted from content licensed under the Open Government Licence v3.0.
For details, see https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/.
Original source: https://www.gov.uk/
Made by AI. If you spot anything of concern write us at contact@cybach.com. We’ll promptly correct irregularities.